| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.1 |